We are live on ! Find out more
TCM

Traynor Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 62.36%
This Fund
S&P 500
This Quarter Est. Return
+5.92%
1 Year Est. Return
+62.36%
3 Year Est. Return
+225.14%
5 Year Est. Return
+309.6%
10 Year Est. Return
+1,325.66%
AUM
$210M
AUM Growth
+$7.69M
Cap. Flow
+$4.27M
Cap. Flow %
2.03%
Top 10 Hldgs %
44.48%
Holding
178
New
16
Increased
72
Reduced
69
Closed
10

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$840K
2
AAPL icon
Apple
AAPL
+$728K
3
MO icon
Altria Group
MO
+$501K
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$439K
5
SNAP icon
Snap
SNAP
+$408K

Top Sells

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$516K
2
AMZN icon
Amazon
AMZN
+$363K
3
QCOM icon
Qualcomm
QCOM
+$343K
4
VMC icon
Vulcan Materials
VMC
+$287K
5
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$239K

Sector Composition

Rank Sector Weight
1 Technology 11.78%
2 Communication Services 11.14%
3 Healthcare 9.45%
4 Consumer Discretionary 7.27%
5 Industrials 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FSTA icon
101
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.41B
$397K 0.19%
12,272
-739
-6% -$24.4K
KMI icon
102
Kinder Morgan
KMI
$69.9B
$384K 0.18%
19,905
+527
+3% +$10.3K
IXN icon
103
iShares Global Tech ETF
IXN
$8.43B
$376K 0.18%
15,990
– –
HYS icon
104
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.74B
$369K 0.18%
3,644
-92
-2% -$9.31K
CHY
105
Calamos Convertible and High Income Fund
CHY
$1.02B
$368K 0.18%
31,024
-553
-2% -$6.54K
HSBC icon
106
HSBC
HSBC
$370B
$368K 0.18%
8,194
+613
+8% +$27.1K
IJK icon
107
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
$364K 0.17%
7,224
-704
-9% -$34.7K
VNQ icon
108
Vanguard Real Estate ETF
VNQ
$39.3B
$361K 0.17%
4,352
+225
+5% +$18.8K
ITA icon
109
iShares US Aerospace & Defense ETF
ITA
$14.4B
$356K 0.17%
4,014
– –
AKAM icon
110
Akamai
AKAM
$17.1B
$354K 0.17%
7,500
+399
+6% +$19.1K
UNP icon
111
Union Pacific
UNP
$173B
$354K 0.17%
3,056
+9
+0.3% +$965
BMY icon
112
Bristol-Myers Squibb
BMY
$134B
$352K 0.17%
5,592
-1,320
-19% -$77.1K
PCG icon
113
PG&E
PCG
$38.4B
$344K 0.16%
5,059
– –
META icon
114
Meta Platforms (Facebook)
META
$1.5T
$340K 0.16%
2,018
-423
-17% -$70.6K
TEVA icon
115
Teva Pharmaceuticals
TEVA
$40.2B
$335K 0.16%
+19,502
New +$439K
SLB icon
116
SLB Ltd
SLB
$73.2B
$327K 0.16%
4,728
-176
-4% -$11.6K
EEM icon
117
iShares MSCI Emerging Markets ETF
EEM
$28.9B
$325K 0.15%
7,341
-426
-5% -$18.8K
ICLR icon
118
Icon
ICLR
$12.2B
$320K 0.15%
2,742
-125
-4% -$13.3K
HUN icon
119
Huntsman Corp
HUN
$1.76B
$319K 0.15%
11,687
-141
-1% -$3.76K
CVS icon
120
CVS Health
CVS
$134B
$314K 0.15%
3,864
+188
+5% +$14.9K
KWEB icon
121
KraneShares CSI China Internet ETF
KWEB
$5.69B
$299K 0.14%
+5,300
New +$289K
IBM icon
122
IBM
IBM
$213B
$293K 0.14%
2,105
+1
+0% +$139
SCHW
123
Charles Schwab
SCHW
$184B
$286K 0.14%
6,554
-6
-0.1% -$249
EOG icon
124
EOG Resources
EOG
$77.6B
$278K 0.13%
2,880
-2,124
-42% -$192K
GT icon
125
Goodyear
GT
$2.02B
$274K 0.13%
8,291
+12
+0.1% +$390
3 4
5
6 7

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
SCP
Seizert Capital Partners Birmingham, Michigan $2.17B AUM 11.2% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
MMLI
Massachusetts Mutual Life Insurance Springfield, Massachusetts $2.17B AUM 48.68% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM

Traynor Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Traynor Capital Management held 178 positions worth $210M, up 3.8% from $203M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Traynor Capital Management's Q3 2017 filing shows 16 new, 72 increased, 69 reduced and 10 closed positions. Its largest new stake was Teva Pharmaceuticals: 19,502 shares worth $335K. The largest sale was Alnylam Pharmaceuticals, an estimated $516K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Communication Services and Healthcare.

  • Traynor Capital Management's largest Q3 2017 buy was Teva Pharmaceuticals: 19,502 shares worth $335K.
  • Traynor Capital Management added most to Intuitive Surgical in Q3 2017, an estimated $840K increase.
  • Traynor Capital Management's biggest Q3 2017 reduction was Amazon, cutting an estimated $363K.
  • Traynor Capital Management fully exited Alnylam Pharmaceuticals in Q3 2017, selling an estimated $516K.
  • Traynor Capital Management's ten largest holdings make up 44% of its $210M portfolio in Q3 2017.
  • Traynor Capital Management opened 16 new positions and closed 10 in Q3 2017.
  • Traynor Capital Management's portfolio value rose 3.8% quarter-over-quarter to $210M.

Based on Traynor Capital Management's 13F filing for Q3 2017, filed 27 Oct 2017.